RCUK (Research Councils UK) prepares to allocate £2.9billion science budget:
This article was originally published in Clinica
Executive Summary
Research Councils UK has welcomed the government's pledge to increase the science budget to £2.9bn ($4.6bn) by 2005-06, as it prepares to discuss how the funding should be allocated. The budget (see Clinica No 1016, p 7) includes a £300m contribution to the £500m per annum capital fund for research infrastructure; additional funding is to be allocated to establishing large research facilities. Launched in May 2002, the RCUK comprises seven research councils, including the Medical Research Council, the Biotechnology and Biological Sciences Research Council and the Council for the Central Laboratory of the Research Councils. The RCUK is due to publish details of the budget allocation in November.
You may also be interested in...
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip
With One Launch Under Way, SpringWorks Ramps Up For A Second
The company initiated a rolling submission with the US FDA for mirdametinib, a MEK inhibitor that is poised to be its second commercial product for a rare disease.
Finance Watch: Ten IPOs So Far In 2024, But Returns To Date Are Subpar
Public Company Edition: This year’s newly public companies are trading an average of 9.7% below their IPO prices, including the two most recent debuts, Boundless Bio and Contineum. Also, Nkarta, Praxis and Nurix grossed $240m, $200m and $175m, respectively, in follow-on offerings.